In Vitro Diagnostics Business Outlook, 2026 - Volume 5, Issue 1 - Focus on Reimbursement
Description
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is undergoing constant change and growth.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
Please Note: Single user allows for up to 3 users for this report.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
- Market Data and Forecasts
- Comprehensive Market View
- M&A Activity Tracking
- Industry & Region Watch
- In-Depth News Analysis
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
- Reimbursement trends
- Quality control reagents
- Cardiac markers
- STI point-of-care testing
- Non-respiratory infectious diseases
- An overall IVD market trend analysis
- A forward-looking forecast of the respiratory testing market through 2027
- And more!
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
30 Pages
- MARKET ANALYSIS: REIMBURSEMENT
- OVERVIEW OF IVD REIMBURSEMENT
- OUTLOOK: REIMBURSEMENT
- Figure: CMS Average Reimbursement Trend: 40+ High-Frequency Clinical Laboratory Test Codes
- Table: CMS Reimbursement Limit by Clinical Laboratory Test Code, 2010, 2015, 2020, and 2025
- Table: Select Companies/Products Expected 2026 Reimbursement Impact
- Table: Summary of Key Reimbursement Drivers
- EXECUTIVE NEWS BRIEFING
- BRIEFINGS
- Kiffik Biomedical Closes Series A Financing
- NeoGenomics Appoints Jack Kenny to Board of Directors
- Cardio Diagnostics Launches Precision CHD Test in India
- Cyclomics Closes €2.5 Million Investment Round
- Truvian Appoints New Chief Medical and Strategy Officer
- Alamar Biosciences Closes $50 Million in New Capital
- Alamar Biosciences Welcomes New CSO
- Hummingbird Diagnostics Appoints New CEO
- Precede Biosciences Nabs $83.5 Million in Total Financing
- FINANCIAL HIGHLIGHTS
- AGILENT FULL YEAR FISCAL 2025 SALES UP 7% IN BUSINESS YOY
- Figure: Agilent Sales by Business, FY 2024 and 2025 ($)
- Figure: Agilent Sales by Business, FY 2025 Quarterly Performance ($)
- Table: Agilent Revenue Mix, by Type, FY 2025 (%)
- Figure: Agilent FY 2025 Regional Sales Breakdown Distribution (%)
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- INDUSTRY WATCH COVID-19/FLU UPDATE
- REGION WATCH
- AUSTRALIA
- Figure: Australia Exports, Distribution by Industry Segment, 2023 ($ billion)
- Figure: Australia IVD Market Sales Trend, 2020-2025 ($ million)
- BROAD-BASED COMPANY ANNOUNCEMENTS
- ANNOUNCEMENTS
- Mira Precision Health Launches ToxNav in U.S.
- Beckton Dickinson Receives FDA Clearance and CE Marking
- QuidelOrtho Captures FDA Clearance or VITROS Immunodiagnostic
- FDA Proposes Reclassification of Companion Diagnostic Assays
- Congress Discusses PAMA
- MeMed Accelerates AI-enabled Acute-Care Diagnostics
- Truvian Health Snags Clearance for Nine Additional Analytes
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
